We are live on ! Find out more
PPH icon

VanEck Pharmaceutical ETF
PPH

114 hedge funds and large institutions have $510M invested in VanEck Pharmaceutical ETF in 2022 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 22 increasing their positions, 25 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

698% more call options, than puts

Call options by funds: $3.29M | Put options by funds: $412K

300% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 10

33% more funds holding

Funds holding: 86 → 114 (+28)

23% more capital invested

Capital invested by funds: $416M → $510M (+$94.3M)

10.69% more ownership

Funds ownership: 77.28% → 87.97% (+11%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

12% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 25

Holders
114
Holders Change
+28
Holders Change %
+32.56%
% of All Funds
1.83%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
40
Increased
22
Reduced
25
Closed
10
Calls
$3.29M
Puts
$412K
Net Calls
+$2.88M
Net Calls Change
-$4.11M

Top Buyers

Rank Fund Capital Flow
1
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$25.4M
2
Bank of America
Bank of America
North Carolina
+$15.9M
3
PCIA
Prime Capital Investment Advisors
Kansas
+$11.2M
4
VAS
Valicenti Advisory Services
New York
+$5.31M
5
AF
Alerus Financial
North Dakota
+$3.5M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$18.4M
2
NI
Noked Israel
Israel
-$9.41M
3
UBS Group
UBS Group
Switzerland
-$7.18M
4
TRCT
Tower Research Capital (TRC)
New York
-$3.48M
5
HF
HRT Financial
New York
-$3.02M
Name Holding Trade Value Shares
Change 		Change in
Stake
BBPWM
101
Blue Bell Private Wealth Management
Pennsylvania
$6.06K – – –
FWM
102
Focused Wealth Management
New York
$4.98K +$4.72K +64 New
MIM
103
Macroview Investment Management
Maryland
$4.9K – – –
AIM
104
Anchor Investment Management
South Carolina
$4.51K – – –
CAS
105
Coppell Advisory Solutions
Texas
$4.05K +$3.84K +52 New
CASC
106
Coppell Advisory Solutions Corp
Texas
$4.05K +$3.84K +52 New
VanEck Associates
107
VanEck Associates
New York
$4K – – –
VF
108
VitalStone Financial
Texas
$4K +$4.06K +55 New
SWA
109
SOA Wealth Advisors
New York
$2.58K – – –
IWA
110
IVC Wealth Advisors
Pennsylvania
$1.63K +$1.79M +24,240 New
AF
111
Affiance Financial
Minnesota
$311 +$295 +4 New
HIA
112
Harbor Investment Advisory
Maryland
$159 – – –
GFPC
113
Global Financial Private Client
Florida
$78 -$3.69K -50 -98%
HNB
114
Huntington National Bank
Ohio
$78 – – –
NI
115
Noked Israel
Israel
– -$9.41M -140,000 Closed
TRCT
116
Tower Research Capital (TRC)
New York
– -$3.48M -51,808 Closed
Jane Street
117
Jane Street
New York
– -$1.45M -21,530 Closed
MOS
118
MGO One Seven
Ohio
– -$949 -14,123 Closed
Walleye Capital
119
Walleye Capital
New York
– -$479K -7,127 Closed
Qube Research & Technologies (QRT)
120
Qube Research & Technologies (QRT)
United Kingdom
– -$358K -5,327 Closed
TSS
121
Two Sigma Securities
New York
– -$290K -4,319 Closed
AWM
122
AE Wealth Management
Kansas
– -$221K -3,282 Closed
ACK
123
Andrew C. Karlinski
– -$58K -866 Closed
EIP
124
Ellis Investment Partners
Pennsylvania
– -$17K -265 Closed
CG
125
Cutler Group
California
– +$221 +3 New
1 2 3 4
5

PPH Hedge Fund Activity: Q4 2022 in Review

114 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in VanEck Pharmaceutical ETF (PPH) for Q4 2022, worth a combined $510M — up 23% from $416M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new PPH positions and 10 closed out — a net gain of 30 holders — while 22 added to existing stakes and 25 trimmed.

The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, opening a new position worth an estimated $25.4M. The largest seller was Goldman Sachs, cutting an estimated $18.4M.

  • 114 institutional investors held VanEck Pharmaceutical ETF (PPH) as of Q4 2022, up from 86 in Q3 2022.
  • Funds reported $510M of VanEck Pharmaceutical ETF stock for Q4 2022, up 23% quarter-over-quarter.
  • 40 funds opened new VanEck Pharmaceutical ETF positions in Q4 2022 and 10 closed out, a net change of +30 holders.
  • The largest VanEck Pharmaceutical ETF buyer in Q4 2022 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $25.4M added.
  • The largest VanEck Pharmaceutical ETF seller in Q4 2022 was Goldman Sachs, an estimated $18.4M sold.

Based on aggregated 13F filings for Q4 2022.